The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 2, 2008, Pages 101-108

  Ramakers, I H G B ^a   Visser, P J ^a,c   Aalten, P ^a   Bekers, O ^b   Sleegers, K ^d   Van Broeckhoven, C L ^d   Jolles, J ^a   Verhey, F R J ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; Apolipoprotein E; Memory strategies; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGE; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEMORY; MEMORY DISORDER; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MEMORY DISORDERS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 51849108660     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144072     Document Type: Article

References (63)

1. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
2. Small BJ, Rosnick CB, Fratiglioni L, Backman L: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004;19:592-600.
3. van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM: Cognitive impairment in Alzheimer's disease is modified by APOE genotype. Dement Geriatr Cogn Disord 2007;24:98-103.
4. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, Berry-Kravis E, Bach J, Fox JH, Evans DA, Bennett DA: The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002;59:1154-1160.
5. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC: Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-362.
6. Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ: Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology 2007;21:158-169.
7. Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC: Impact of APOE in mild cognitive impairment. Neurology 2004;63:1898-1901.
8. Visser PJ, Kester A, Jolles J, Verhey F: Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201-1207.
9. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE: Amyloid mediates the association of apolipoprotein E ε4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry 2005;76:1194-1199.
10. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN: Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 2006;11:721-736.
11. Nilsson LG, Adolfsson R, Backman L, Cruts M, Nyberg L, Small BJ, Van Broeckoven C: The influence of APOE status on episodic and semantic memory: data from a population-based study. Neuropsychology 2006;20:645-657.
12. Carlesimo GA, Mauri M, Graceffa AM, Fadda L, Loasses A, Lorusso S, Caltagirone C: Memory performances in young, elderly, and very old healthy individuals versus patients with Alzheimer's disease: evidence for discontinuity between normal and pathological aging. J Clin Exp Neuropsychol 1998;20:14-29.
13. Delis DC, Massman PJ, Butters N, Salmon DP, Cermak LS, Kramer JK: Profiles of demented and amnestic patients of the California Verbal Learning Test: implications for the assessment of memory disorders. J Consult Clin Psychol 1991;3:19-26.
14. Perri R, Carlesimo GA, Serra L, Caltagirone C: Characterization of memory profile in subjects with amnestic mild cognitive impairment. J Clin Exp Neuropsychol 2005;27:1033-1055.
15. Verhey FR, Jolles J, Ponds RW, Rozendaal N, Plugge LA, de Vet RC, Vreeling FW, van der Lugt PJ: Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci 1993;5:78-85.
16. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
17. Feldman HH, Jacova C: Mild cognitive impairment. Am J Geriatr Psychiatry 2005;13:645-655.
18. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-924.
19. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan DR, St George-Hyslop PH: A prospective study of the clinical utility of APOE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996;46:149-154.
20. Geslani DM, Tierney MC, Herrmann N, Szalai JP: Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord 2005;19:383-389.
21. Storandt M, Grant EA, Miller JP, Morris JC: Longitudinal course and neuropathologic outcomes in original vs. revised MCI and in pre-MCI. Neurology 2006;67:467-473.
22. Visser PJ, Verhey F: Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. Psychol Med 2007;37:1-10.
23. Visser PJ, Verhey FR, Ponds RW, Cruts M, Van Broeckhoven CL, Jolles J: Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry 2000;15:363-372.
24. Brand N, Jolles J: Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112:201-210.
25. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
26. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
27. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
28. Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J: Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 2005;11:290-302.
29. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 2006;13:62-79.
30. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: Normative data for the animal, profession and letter m naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc 2006;12:80-89.
31. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
32. Brandt J, Spencer M, Folstein M: The telephonic interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
33. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders IV, ed 4. Washington, American Psychiatric Association, 1994.
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
35. Tulving E: Subjective organization in free recall of 'unrelated' words. Psychol Rev 1962;69:344-354.
36. Bousfield AK, Bousfield WA: Measurements of clustering and of sequential constancies in repeated free recall. Psychol Rep 1966;19:935-942.
37. Delis DC, Kramer JK, Kaplan E, Ober BA: California Verbal Learning Test. New York, Psychological Corporation, 1987.
38. Sternberg RJ, Tulving E: The measurement of subjective organization in free recall. Psychol Bull 1977;84:539-556.
39. Saan RJ, Deelman BG: Nieuwe 15-woorden test a en b (15wt-a en 15wt-b); Neuropsychologische diagnostiek: Handboek. Amsterdam, Swets & Zeitlinger, 1986.
40. Mulder JL, Dekker R, Dekker PH: Verbale leer en geheugen test. Lisse, Swets & Zeitlinger, 1996.
41. Bekers O, op den Buijsch RA, de Vries JE, Wijnen PA, van Dieijen-Visser MP: Capillary electrophoretic detection in apolipoprotein E genotyping. Electrophoresis 2002;23:1878-1881.
42. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM: Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998;55:964-968.
43. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
44. United Nations Educational, Scientific and Cultural Organization (UNESCO): International Standard Classification of Education (ISCED). Paris, 1976.
45. Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ: Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 2005;62:953-957.
46. Fletcher PC, Shallice T, Dolan RJ: The functional roles of prefrontal cortex in episodic memory. I. Encoding. Brain 1998;121:1239-1248.
47. Fletcher PC, Shallice T, Frith CD, Frackowiak RS, Dolan RJ: The functional roles of prefrontal cortex in episodic memory. II. Retrieval. Brain 1998;121:1249-1256.
48. Savage CR, Deckersbach T, Heckers S, Wagner AD, Schacter DL, Alpert NM, Fischman AJ, Rauch SL: Prefrontal regions supporting spontaneous and directed application of verbal learning strategies: evidence from PET. Brain 2001;124:219-231.
49. Kramer JH, Rosen HJ, Du AT, Schuff N, Hollnagel C, Weiner MW, Miller BL, Delis DC: Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology 2005;19:799-805.
50. Reitan R: Validity of the Trial Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271-276.
51. Stroop J: Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
52. Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S: APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 2007;21:1-8.
53. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J: Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-289.
54. Scarmeas N, Habeck CG, Stern Y, Anderson KE: APOE genotype and cerebral blood flow in healthy young individuals. JAMA 2003;290:1581-1582.
55. Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC: Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med 2006;4:1.
56. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K: Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006;129:2908-2922.
57. Scarmeas N, Habeck CG, Hilton J, Anderson KE, Flynn J, Park A, Stern Y: APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry 2005;76:1440-1444.
58. Filbey FM, Slack KJ, Sunderland TP, Cohen RM: Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 2006;17:1585-1590.
59. Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW: Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry 2006;163:1603-1610.
60. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW: Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-456.
61. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL: Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 2006;63:63-72.
62. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH: Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006;67:1221-1224.
63. Jolles J, Houx PJ, Van Boxtel MPJ, Ponds RWHM: Maastricht Aging Study: Determinants of Cognitive Aging. Maastricht, Neuropsych Publishers, 1995.